RCT | Low-dose Decitabine vs. low-dose Azacitidine in lower-risk myelodysplastic syndromes.
SPECIALTIES,
Low-Dose Decitabine versus Low-Dose Azacitidine in Lower-Risk MDS – NEJM…
Low-Dose Decitabine versus Low-Dose Azacitidine in Lower-Risk MDS.
Overview of attention for article published in NEJM Evidence, August 2022
Altmetric Badge
About this Attention Score
-
In the top 5% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (97th percentile)
-
High Attention Score compared to outputs of the same age and source (80th percentile)
Mentioned by
- news
- 5 news outlets
- blogs
- 1 blog
- 82 X users
- video
- 1 YouTube creator
- guideline
- 1 clinical guideline source
Readers on
- mendeley
- 19 Mendeley